Related Experiment Video
Updated: May 24, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens
Marie Desnos-Ollivier1, Vincent Robert, Dorothée Raoux-Barbot
1Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris, France.
Abstract:
New molecular identification techniques and the increased number of patients with various immune defects or underlying conditions lead to the emergence and/or the description of novel species of human and animal fungal opportunistic pathogens. Antifungal susceptibility provides important information for ecological, epidemiological and therapeutic issues. The aim of this study was to assess the potential risk of the various species based on their antifungal drug resistance, keeping in mind the methodological limitations. Antifungal susceptibility profiles to the five classes of antifungal drugs (polyens, azoles, echinocandins, allylamines and antimetabolites) were determined for 1698 yeast reference strains belonging to 992 species (634 Ascomycetes and 358 Basidiomycetes). Interestingly, geometric mean minimum inhibitory concentrations (MICs) of all antifungal drugs tested were significantly higher for Basidiomycetes compared to Ascomycetes (p<0.001). Twenty four strains belonging to 23 species of which 19 were Basidiomycetes seem to be intrinsically "resistant" to all drugs. Comparison of the antifungal susceptibility profiles of the 4240 clinical isolates and the 315 reference strains belonging to 53 shared species showed similar results. Even in the absence of demonstrated in vitro/in vivo correlation, knowing the in vitro susceptibility to systemic antifungal agents and the putative intrinsic resistance of yeast species present in the environment is important because they could become opportunistic pathogens.
Insights
Emerging fungal pathogens show varying antifungal resistance. Basidiomycetes yeasts exhibit higher drug resistance than Ascomycetes, with some species intrinsically resistant to all tested antifungal drugs.
Area of Science:
- Medical Mycology
- Antimicrobial Resistance
- Fungal Pathogenesis
Background:
- Novel fungal species are increasingly identified as opportunistic pathogens in humans and animals due to immune defects and advanced diagnostics.
- Antifungal susceptibility data is crucial for understanding ecological, epidemiological, and therapeutic aspects of fungal infections.
Purpose of the Study:
- To evaluate the antifungal drug resistance profiles of various yeast species.
- To assess the potential risk posed by different fungal species based on their drug resistance patterns.
- To identify yeasts with intrinsic resistance to antifungal agents.
Main Methods:
- Antifungal susceptibility testing was performed on 1698 yeast reference strains from 992 species (634 Ascomycetes, 358 Basidiomycetes) against five classes of antifungal drugs: polyenes, azoles, echinocandins, allylamines, and antimetabolites.
- Minimum inhibitory concentrations (MICs) were determined.
- Profiles were compared between Ascomycetes and Basidiomycetes, and between reference strains and clinical isolates.
Main Results:
- Basidiomycetes species showed significantly higher geometric mean MICs for all tested antifungal drugs compared to Ascomycetes (p<0.001).
- Twenty-four strains, including 19 Basidiomycetes species, displayed intrinsic resistance to all tested antifungal drugs.
- Antifungal susceptibility profiles of clinical isolates were consistent with those of reference strains for shared species.
Conclusions:
- Fungal species, particularly Basidiomycetes, exhibit significant intrinsic antifungal resistance.
- Understanding in vitro antifungal susceptibility and intrinsic resistance is vital for managing potential opportunistic fungal infections.
- This knowledge aids in ecological, epidemiological, and therapeutic strategies against emerging fungal pathogens.
Related Concept Videos
Fungal Phylum Ascomycota
Antifungal Agents
Fungal Group Zygomycota
Fungal Phylum Microsporidia

